| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.04 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |